Rehabilitation of Conversion Gait Disorder

Brief Summary

Official Title: “Patients With Conversion Gait Disorder – Effect on Treatment and Common Gait Patterns. Randomized Clinical Trial”

Evaluating the effects in functional status after three weeks of cognitive – and behavioural rehabilitation on patients with gait disorder. The patients are followed up as after 1 and 12 months to study if any improvement is still present. The patients are being recruited from neurological units. The intervention is explanation of symptoms, positive reinforcement of normal behaviour and absence reinforcement of dysfunctional behaviour. In addition the study aims at describing typical gait patterns at patients with gait disorder by using biomechanical measurements (EKG).

  • Study Type: Interventional
  • Study Design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment
  • Study Primary Completion Date: September 2010

Detailed Clinical Trial Description

Patients are being recruited from neurological unit/ div and out patients department of SSR and are randomized to treatment or control group. Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.

Interventions Used in this Clinical Trial

  • Other: Rehabilitation
    • Three weeks of rehabilitation in Hospital.

Outcome Measures for this Clinical Trial

Primary Measures

  • Change in gait patterns
    • Time Frame: three weeks
      Safety Issue?: No

Secondary Measures

  • Improved life quality
    • Time Frame: 12 months
      Safety Issue?: No

Criteria for Participation in this Clinical Trial

Inclusion Criteria

  • To determine the changes in functional status after three weeks of multidisciplinary rehabilitation in patients with conversion walking disorder.

Exclusion Criteria

  • Essential gait disorders do to conversion symptoms and willingness to participate in either of the two groups with informed consent are required.

Gender Eligibility for this Clinical Trial: Both

Minimum Age for this Clinical Trial: 18 Years

Maximum Age for this Clinical Trial: 69 Years

Are Healthy Volunteers Accepted for this Clinical Trial: No

Clinical Trial Investigator Information

  • Lead Sponsor
    • Oslo University Hospital
  • Collaborator
    • Norwegian School of Sport Sciences
  • Provider of Information About this Clinical Study
    • Principal Investigator: Annika A. Jordbru, PhD student – Oslo University Hospital
  • Overall Official(s)
    • Georg Høyer, DH, Study Chair, National committees for research ethics in Norway” for REK

Source

Clinical Trials content is provided directly by the US National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of information about a specific clinical trial contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT01422278